The co-presence of the two deletions results in a favorable outcome in B-ALL patients with an ERG deletion, with an 8-year EFS and overall survival (OS) of 86.4% and 95.6% respectively, even when associated with frequent IKZF1 deletions [86]. Here, IKZF1 is linked to acute lymphoblastic leukemia.